Prof. M. Viswanathan: The pride of Asia in diabetology

Satyavani Kumpatla, Vijay Viswanathan, Ambady Ramachandran, Viswanathan Mohan
{"title":"Prof. M. Viswanathan: The pride of Asia in diabetology","authors":"Satyavani Kumpatla, Vijay Viswanathan, Ambady Ramachandran, Viswanathan Mohan","doi":"10.4103/jod.jod_108_23","DOIUrl":null,"url":null,"abstract":"Dear Editor, Prof. M. Viswanathan (Prof. MV) was not just a doyen in the field of diabetes but also an astute clinician, teacher, researcher, and administrator. He made substantial contributions to diabetes care and research for nearly five decades. He was one of the most internationally recognized research scientists in India of his time. Prof. MV published more than 250 peer-reviewed research papers in prestigious national and international journals. His work propelled India to the forefront of diabetes care and research, and he played a pivotal role in elevating the nation’s status in this field. Born on August 26, 1923, in Kerala, India to Mr. A. K. Menon and Dr. M. Madhavi Amma (who was one of the first doctors of Kerala), Prof. MV’s career in medicine was greatly influenced by his mother. He pursued medicine at Stanley Medical College, Madras graduating in 1946, and worked as a House Physician. At a time, when diabetes was not regarded as a special field of study, he established the first organized diabetes clinic in India in 1948 at the Stanley Medical College. His dedication led to his promotion as Hon. Asst. Prof of Medicine and later as Hon. Prof of Medicine at the same college. In 1952, he married Sarada, who provided unwavering support throughout his life. Prof. MV voluntarily left government service with a view to setting up a hospital and research center devoted to clinical research in diabetes, the first of its kind in India. He also built up his private practice as a full-time Diabetologist. His achievements include the prestigious Dr.B.C.Roy National Award in 1982 for the development of the specialty of diabetology in India by the Medical Council of India. He has the unique honor of being the organizing secretary of three successive Association of Physicians of India (API) conferences. He held the posts of President, Association of Physicians of India, and President of the Scientific Section of the Diabetes Association of India with great distinction. He was also a member of the American Diabetes Association, British Diabetic Association, International Diabetes Federation, European Association for Study of Diabetes (EASD), and the Research Society for Study of Diabetes in India (RSSDI). At his center, Prof. MV created a modern reference library with well-organized resources for diabetes education and research. He also maintained a unique medical records system which served as a database for most of his long-term research findings. Many institutions sought his guidance in setting up modern and well-organized record-keeping departments. Prof. MV research efforts garnered numerous national and international honors and awards. He organized scientific conferences in India and also presented his research work at seminars and conferences worldwide. His primary objectives were to ensure high-quality diabetes research in India and more importantly to prevent and conquer diabetes. He pursued these goals relentlessly and with a missionary zeal until his passing on March 1, 1996. Quite appropriately, Prof. MV is recognized and finally referred to as the “Father of Diabetology” in India. Research Journey of Prof. M. Viswanathan In the natural history of type 2 diabetes, most individuals pass through a phase of impaired glucose regulation who eventually develop diabetes. In 1954, Fajans and Conn first identified the ’Prediabetes state’ as a precursor to type 2 diabetes.[1] They described the cortisone GTT as a possible approach for the detection of the prediabetes state.[2]The research work on this was taken up by Prof. MV as early as 1959. A well-designed study in 1962 focused on the relatives of individuals with diabetes, comparing them to a control group with no relatives with diabetes, subjected them to a glucose tolerance test after steroid administration revealed higher abnormal glucose responses in those with a family history of diabetes, especially those under 30 years old. The study also considered the impact of obesity, comparing findings with Western literature from 1954 to 1961. This research pioneered a method to identify individuals at risk of future diabetes ultimately guiding Prof. MV’s work toward diabetes prevention.[3] Prof. MV strongly believed that diabetes can be prevented and emphasized the significance of individual and community-based preventive strategies. He highlighted the basic risk factors for diabetes which eventually lead to the development of diabetes. Heredity was identified as a crucial risk factor, with a focus on close relatives and offspring of individuals with diabetes. Environmental factors, modifiable in contrast to genetics, played a pivotal role. Other risk factors such as obesity, repeated pregnancies, physical inactivity, and stress were also addressed. Screening high-risk individuals allowed for effective preventive measures. His observations convinced him about the need for the prevention of diabetes and he explored ways and means of halting the progression of this pathological process.[4-6] He stressed the need for recognizing and reversing the natural history of diabetes through primary prevention efforts. The studies on hormonal profiles in the offspring offered very interesting and useful information. The findings revealed early abnormalities in beta cell activity. In the early 1980s, his research on insulin and c-peptide levels laid the foundation for future studies. These levels were measured during oral glucose tolerance tests, indicating lower beta cell function in impaired glucose tolerance (IGT) and diabetes, alongside decreased hepatic extraction of insulin.[7] Other workers reported similar findings in the Western population. In 1983, Rossell et al.[8] suggested that hepatic insulin extraction was decreased in obesity. Another study by Bonora et al.[9] also indicated that peripheral hyperinsulinemia in IGT was a result of both pancreatic hypersecretion and diminished hepatic insulin extraction. Prof. MV’s last publication on the preventive aspect emphasized the importance of weight loss to maintain normal glucose tolerance, even in non-obese individuals with a strong family history of diabetes. He highlighted the role of physical activity and proper diet in mitigating diabetes risk.[10] Prof. MV was far ahead of his time in advocating for type 2 diabetes prevention, promoting lifestyle intervention at the earliest signs of glucose intolerance, even before the NDDG and WHO defined IGT. Prof. MV revolutionized nutrition research in diabetes with his ground-breaking research. The diet of the Indian population is cereal-based and rich in carbohydrates. It was believed at the time, in India that people with diabetes should avoid rice completely. Prof. MV found that the prescribed dietary changes could not be adhered to by many patients for a long period of time. Hence, he evolved the concept of the restricted calorie high-carbohydrate high-fiber (HCHF) diet whereby the patients were allowed to follow their usual food pattern to achieve better dietary adherence and patient cooperation, but with restriction and avoidance of free sugars. He proved that a South Indian diet with rice but with restriction of calories, was ideal for people with diabetes. This was a major research contribution made by Prof. MV in diabetes nutrition research. Prof. MV noticed that the diet of our people was deficient in protein. He advocated increasing protein in their diet by adding vegetable protein in the form of pulses and legumes. This resulted in not only making the food a more balanced one but also the glycaemic control achieved within a short period. His innovative dietary strategy achieved glycaemic and lipid control, countering prior beliefs. This pattern of diet is now regarded as the more practicable diet for people with diabetes. Prof. MV extensively studied familial aggregation of type 2 diabetes, emphasizing the impact of genetics on the disease’s prevalence.[11] His earlier study analyzed 4000 individuals with type 2 diabetes for the number and classification of relatives with diabetes and demonstrated the presence of a positive family history of diabetes in 33.9% of study participants highlighting familial aggregation of diabetes. Another of Prof. MV’s studies involved a study of 2600 conjugal parents with diabetes.[12] The study showed path-breaking results with nearly 62% of offspring having a risk when both parents had diabetes, and when only one parent had diabetes the risk was 22%. His collaboration with UK researchers for advanced complex segregation genetic analysis paved the way to identify diabetes susceptibility genes among the Indian population. These observations had important implications for the search for genes involved in the pathogenesis of type 2 diabetes. Remission in diabetes may be defined as a period when blood glucose levels are back to normal levels and there is no need for anti-diabetic treatment. The concept of remission of diabetes has been widely recognized recently. It is therefore surprising to note that Prof. MV recognized the concept of “Remission in Diabetes” as far back as 1987.[13] His research highlighted the role of lifestyle changes and medical intervention in achieving remission, providing valuable insights into the natural history of diabetes. In conclusion, the profound contributions of Prof. MV to the field of diabetes are valid to this day and his visionary approach to diabetes research had a lasting impact. His emphasis on primary prevention, innovative dietary interventions, and pioneering research on familial aggregation and clinical management has significantly advanced the field and contributed to our understanding of diabetes. His work challenged prevailing beliefs and advanced our knowledge of diabetes, offering valuable insights that continue to shape diabetes research and care even today. His work continues to influence and inspire researchers, clinicians, and individuals living with diabetes. He is truly the pride of Asia in Diabetology. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.","PeriodicalId":15627,"journal":{"name":"Journal of Diabetology","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jod.jod_108_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Editor, Prof. M. Viswanathan (Prof. MV) was not just a doyen in the field of diabetes but also an astute clinician, teacher, researcher, and administrator. He made substantial contributions to diabetes care and research for nearly five decades. He was one of the most internationally recognized research scientists in India of his time. Prof. MV published more than 250 peer-reviewed research papers in prestigious national and international journals. His work propelled India to the forefront of diabetes care and research, and he played a pivotal role in elevating the nation’s status in this field. Born on August 26, 1923, in Kerala, India to Mr. A. K. Menon and Dr. M. Madhavi Amma (who was one of the first doctors of Kerala), Prof. MV’s career in medicine was greatly influenced by his mother. He pursued medicine at Stanley Medical College, Madras graduating in 1946, and worked as a House Physician. At a time, when diabetes was not regarded as a special field of study, he established the first organized diabetes clinic in India in 1948 at the Stanley Medical College. His dedication led to his promotion as Hon. Asst. Prof of Medicine and later as Hon. Prof of Medicine at the same college. In 1952, he married Sarada, who provided unwavering support throughout his life. Prof. MV voluntarily left government service with a view to setting up a hospital and research center devoted to clinical research in diabetes, the first of its kind in India. He also built up his private practice as a full-time Diabetologist. His achievements include the prestigious Dr.B.C.Roy National Award in 1982 for the development of the specialty of diabetology in India by the Medical Council of India. He has the unique honor of being the organizing secretary of three successive Association of Physicians of India (API) conferences. He held the posts of President, Association of Physicians of India, and President of the Scientific Section of the Diabetes Association of India with great distinction. He was also a member of the American Diabetes Association, British Diabetic Association, International Diabetes Federation, European Association for Study of Diabetes (EASD), and the Research Society for Study of Diabetes in India (RSSDI). At his center, Prof. MV created a modern reference library with well-organized resources for diabetes education and research. He also maintained a unique medical records system which served as a database for most of his long-term research findings. Many institutions sought his guidance in setting up modern and well-organized record-keeping departments. Prof. MV research efforts garnered numerous national and international honors and awards. He organized scientific conferences in India and also presented his research work at seminars and conferences worldwide. His primary objectives were to ensure high-quality diabetes research in India and more importantly to prevent and conquer diabetes. He pursued these goals relentlessly and with a missionary zeal until his passing on March 1, 1996. Quite appropriately, Prof. MV is recognized and finally referred to as the “Father of Diabetology” in India. Research Journey of Prof. M. Viswanathan In the natural history of type 2 diabetes, most individuals pass through a phase of impaired glucose regulation who eventually develop diabetes. In 1954, Fajans and Conn first identified the ’Prediabetes state’ as a precursor to type 2 diabetes.[1] They described the cortisone GTT as a possible approach for the detection of the prediabetes state.[2]The research work on this was taken up by Prof. MV as early as 1959. A well-designed study in 1962 focused on the relatives of individuals with diabetes, comparing them to a control group with no relatives with diabetes, subjected them to a glucose tolerance test after steroid administration revealed higher abnormal glucose responses in those with a family history of diabetes, especially those under 30 years old. The study also considered the impact of obesity, comparing findings with Western literature from 1954 to 1961. This research pioneered a method to identify individuals at risk of future diabetes ultimately guiding Prof. MV’s work toward diabetes prevention.[3] Prof. MV strongly believed that diabetes can be prevented and emphasized the significance of individual and community-based preventive strategies. He highlighted the basic risk factors for diabetes which eventually lead to the development of diabetes. Heredity was identified as a crucial risk factor, with a focus on close relatives and offspring of individuals with diabetes. Environmental factors, modifiable in contrast to genetics, played a pivotal role. Other risk factors such as obesity, repeated pregnancies, physical inactivity, and stress were also addressed. Screening high-risk individuals allowed for effective preventive measures. His observations convinced him about the need for the prevention of diabetes and he explored ways and means of halting the progression of this pathological process.[4-6] He stressed the need for recognizing and reversing the natural history of diabetes through primary prevention efforts. The studies on hormonal profiles in the offspring offered very interesting and useful information. The findings revealed early abnormalities in beta cell activity. In the early 1980s, his research on insulin and c-peptide levels laid the foundation for future studies. These levels were measured during oral glucose tolerance tests, indicating lower beta cell function in impaired glucose tolerance (IGT) and diabetes, alongside decreased hepatic extraction of insulin.[7] Other workers reported similar findings in the Western population. In 1983, Rossell et al.[8] suggested that hepatic insulin extraction was decreased in obesity. Another study by Bonora et al.[9] also indicated that peripheral hyperinsulinemia in IGT was a result of both pancreatic hypersecretion and diminished hepatic insulin extraction. Prof. MV’s last publication on the preventive aspect emphasized the importance of weight loss to maintain normal glucose tolerance, even in non-obese individuals with a strong family history of diabetes. He highlighted the role of physical activity and proper diet in mitigating diabetes risk.[10] Prof. MV was far ahead of his time in advocating for type 2 diabetes prevention, promoting lifestyle intervention at the earliest signs of glucose intolerance, even before the NDDG and WHO defined IGT. Prof. MV revolutionized nutrition research in diabetes with his ground-breaking research. The diet of the Indian population is cereal-based and rich in carbohydrates. It was believed at the time, in India that people with diabetes should avoid rice completely. Prof. MV found that the prescribed dietary changes could not be adhered to by many patients for a long period of time. Hence, he evolved the concept of the restricted calorie high-carbohydrate high-fiber (HCHF) diet whereby the patients were allowed to follow their usual food pattern to achieve better dietary adherence and patient cooperation, but with restriction and avoidance of free sugars. He proved that a South Indian diet with rice but with restriction of calories, was ideal for people with diabetes. This was a major research contribution made by Prof. MV in diabetes nutrition research. Prof. MV noticed that the diet of our people was deficient in protein. He advocated increasing protein in their diet by adding vegetable protein in the form of pulses and legumes. This resulted in not only making the food a more balanced one but also the glycaemic control achieved within a short period. His innovative dietary strategy achieved glycaemic and lipid control, countering prior beliefs. This pattern of diet is now regarded as the more practicable diet for people with diabetes. Prof. MV extensively studied familial aggregation of type 2 diabetes, emphasizing the impact of genetics on the disease’s prevalence.[11] His earlier study analyzed 4000 individuals with type 2 diabetes for the number and classification of relatives with diabetes and demonstrated the presence of a positive family history of diabetes in 33.9% of study participants highlighting familial aggregation of diabetes. Another of Prof. MV’s studies involved a study of 2600 conjugal parents with diabetes.[12] The study showed path-breaking results with nearly 62% of offspring having a risk when both parents had diabetes, and when only one parent had diabetes the risk was 22%. His collaboration with UK researchers for advanced complex segregation genetic analysis paved the way to identify diabetes susceptibility genes among the Indian population. These observations had important implications for the search for genes involved in the pathogenesis of type 2 diabetes. Remission in diabetes may be defined as a period when blood glucose levels are back to normal levels and there is no need for anti-diabetic treatment. The concept of remission of diabetes has been widely recognized recently. It is therefore surprising to note that Prof. MV recognized the concept of “Remission in Diabetes” as far back as 1987.[13] His research highlighted the role of lifestyle changes and medical intervention in achieving remission, providing valuable insights into the natural history of diabetes. In conclusion, the profound contributions of Prof. MV to the field of diabetes are valid to this day and his visionary approach to diabetes research had a lasting impact. His emphasis on primary prevention, innovative dietary interventions, and pioneering research on familial aggregation and clinical management has significantly advanced the field and contributed to our understanding of diabetes. His work challenged prevailing beliefs and advanced our knowledge of diabetes, offering valuable insights that continue to shape diabetes research and care even today. His work continues to influence and inspire researchers, clinicians, and individuals living with diabetes. He is truly the pride of Asia in Diabetology. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
M. Viswanathan教授:亚洲糖尿病学的骄傲
尊敬的编辑:M. Viswanathan教授(Prof. MV)不仅是糖尿病领域的元老,也是一位精明的临床医生、教师、研究员和管理者。在近50年的时间里,他为糖尿病的治疗和研究做出了重大贡献。他是当时印度最受国际认可的研究科学家之一。他在国内外知名期刊上发表了250多篇经同行评议的研究论文。他的工作将印度推向了糖尿病护理和研究的前沿,他在提升印度在这一领域的地位方面发挥了关键作用。梅农于1923年8月26日出生在印度喀拉拉邦,父母是A. K. Menon先生和M. Madhavi Amma博士(他是喀拉拉邦最早的医生之一)。他在马德拉斯斯坦利医学院攻读医学,1946年毕业,并担任住院医生。当时,糖尿病还没有被视为一个特殊的研究领域,他于1948年在斯坦利医学院建立了印度第一个有组织的糖尿病诊所。他的奉献精神使他晋升为荣誉助理医学教授,后来又成为同一所学院的荣誉医学教授。1952年,他与萨拉达结婚,萨拉达在他的一生中给予了他坚定的支持。MV教授自愿离开政府部门,成立了一家医院和研究中心,致力于糖尿病的临床研究,这是印度第一家此类医院。他还建立了自己的私人诊所,成为一名全职糖尿病专家。他的成就包括1982年由印度医学委员会颁发的著名的b.c. roy博士国家奖,以表彰他在印度糖尿病专科的发展。他有幸连续三次担任印度医师协会(API)会议的组织秘书。他曾担任印度医师协会主席和印度糖尿病协会科学分会主席,并取得了巨大的成就。他也是美国糖尿病协会、英国糖尿病协会、国际糖尿病联合会、欧洲糖尿病研究协会(EASD)和印度糖尿病研究学会(RSSDI)的成员。在他的中心,MV教授创建了一个现代化的参考图书馆,其中有组织良好的糖尿病教育和研究资源。他还拥有一个独特的医疗记录系统,作为他大部分长期研究成果的数据库。许多机构寻求他的指导,建立了现代化和组织良好的记录部门。他的研究工作获得了许多国家和国际上的荣誉和奖项。他在印度组织了科学会议,并在世界各地的研讨会和会议上介绍了他的研究工作。他的主要目标是确保印度高质量的糖尿病研究,更重要的是预防和征服糖尿病。直到1996年3月1日去世,他一直坚持不懈地追求这些目标。在印度,MV教授被公认并最终被称为“糖尿病学之父”。M. Viswanathan教授的研究历程在2型糖尿病的自然历史中,大多数个体都经历了一个葡萄糖调节受损的阶段,最终发展为糖尿病。1954年,Fajans和Conn首次将“糖尿病前期状态”确定为2型糖尿病的前兆。[1]他们将可的松GTT描述为一种检测糖尿病前期状态的可能方法。[2]早在1959年,MV教授就开始了这方面的研究工作。1962年,一项精心设计的研究聚焦于糖尿病患者的亲属,将他们与没有亲属患有糖尿病的对照组进行比较,在类固醇给药后对他们进行葡萄糖耐量试验,结果显示有糖尿病家族史的人,特别是30岁以下的人,血糖异常反应更高。该研究还考虑了肥胖的影响,并将研究结果与1954年至1961年的西方文献进行了比较。这项研究开创了一种识别未来糖尿病风险个体的方法,最终指导MV教授的糖尿病预防工作。[3]MV教授坚信糖尿病是可以预防的,并强调了个人和社区预防策略的重要性。他强调了糖尿病的基本风险因素,这些因素最终导致糖尿病的发展。遗传被确定为一个关键的风险因素,重点关注糖尿病患者的近亲和后代。与遗传因素相比,环境因素是可以改变的,它起着关键作用。其他风险因素,如肥胖、重复怀孕、缺乏体育活动和压力也得到了解决。筛查高危人群可以采取有效的预防措施。 他的观察结果使他相信预防糖尿病的必要性,并探索了阻止这一病理过程进展的方法和手段。[4-6]他强调需要通过初级预防努力认识和扭转糖尿病的自然历史。对后代荷尔蒙谱的研究提供了非常有趣和有用的信息。研究结果揭示了β细胞活性的早期异常。20世纪80年代初,他对胰岛素和c肽水平的研究为以后的研究奠定了基础。这些水平是在口服糖耐量试验中测量的,表明糖耐量受损(IGT)和糖尿病患者的β细胞功能降低,同时肝脏胰岛素提取减少。[7]其他研究人员在西方人群中也报告了类似的发现。1983年Rossell等[8]提出肥胖患者肝脏胰岛素提取减少。Bonora等[9]的另一项研究也表明,IGT中外周高胰岛素血症是胰腺分泌过多和肝脏胰岛素提取减少的结果。MV教授关于预防方面的最后一篇文章强调了减肥对于维持正常葡萄糖耐量的重要性,即使对于有强烈糖尿病家族史的非肥胖个体也是如此。他强调了体育锻炼和合理饮食在降低糖尿病风险方面的作用。[10]MV教授在倡导2型糖尿病预防方面远远领先于他的时代,甚至在NDDG和WHO定义IGT之前,就在葡萄糖耐受不良的早期迹象中提倡生活方式干预。MV教授的开创性研究彻底改变了糖尿病的营养研究。印度人的饮食以谷物为主,富含碳水化合物。当时在印度,人们认为糖尿病患者应该完全不吃米饭。MV教授发现,许多患者不能长期坚持规定的饮食改变。因此,他提出了限制卡路里高碳水化合物高纤维饮食(HCHF)的概念,允许患者遵循他们通常的饮食模式,以达到更好的饮食依从性和患者合作,但限制和避免游离糖。他证明了南印度人吃米饭但限制卡路里的饮食对糖尿病患者来说是理想的。这是MV教授在糖尿病营养学研究方面的重大研究贡献。MV教授注意到我国人民的饮食缺乏蛋白质。他提倡在他们的饮食中加入豆类和豆类形式的植物蛋白来增加蛋白质。这不仅使食物更加均衡,而且在短时间内实现了血糖控制。他创新的饮食策略实现了血糖和血脂的控制,打破了之前的观念。这种饮食模式现在被认为是糖尿病患者更可行的饮食。MV教授广泛研究了2型糖尿病的家族聚集性,强调了遗传对疾病患病率的影响。[11]他早期的研究分析了4000名2型糖尿病患者的亲属数量和分类,发现33.9%的研究参与者有糖尿病家族史,突出了糖尿病的家族聚集性。MV教授的另一项研究涉及对2600名患有糖尿病的夫妻的研究。[12]该研究显示了开创性的结果:当父母双方都患有糖尿病时,近62%的后代有患糖尿病的风险,而当父母只有一方患有糖尿病时,这一风险为22%。他与英国研究人员合作进行了先进的复杂分离遗传分析,为确定印度人群中的糖尿病易感基因铺平了道路。这些观察结果对寻找与2型糖尿病发病机制有关的基因具有重要意义。糖尿病的缓解期可以定义为血糖水平恢复到正常水平并且不需要抗糖尿病治疗的时期。糖尿病缓解的概念最近得到了广泛的认可。因此,令人惊讶的是,MV教授早在1987年就认识到了“糖尿病缓解”的概念。[13]他的研究强调了生活方式改变和医疗干预在实现缓解中的作用,为糖尿病的自然历史提供了有价值的见解。总而言之,MV教授对糖尿病领域的深刻贡献至今仍然有效,他对糖尿病研究的远见卓识产生了持久的影响。他对初级预防、创新饮食干预以及家族聚集和临床管理的开创性研究的重视,极大地推动了该领域的发展,并有助于我们对糖尿病的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Emerging glucagon-based therapies in diabetes mellitus: Toward a better future in diabetes care Eating disorders and type 1 diabetes as a significant problem An update on the role of antihyperglycemic agents in diabetoporosis Effect of combination of Curcuma longa with Emblica officinalis in females with polycystic ovarian syndrome: An open-label, randomized active-controlled, exploratory clinical study Maternally inherited diabetes mellitus and deafness (MIDD): A case report and review of literature
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1